140 related articles for article (PubMed ID: 183198)
21. Pleuropulmonary fibrosis due to bromocriptine treatment for Parkinson's disease.
Todman DH; Oliver WA; Edwards RL
Clin Exp Neurol; 1990; 27():79-82. PubMed ID: 2129961
[TBL] [Abstract][Full Text] [Related]
22. The role of bromocriptine in the treatment of Parkinson's disease.
Stern GM; Lees AJ; Shaw KM; Lander CM
Adv Biochem Psychopharmacol; 1980; 23():267-70. PubMed ID: 7395617
[No Abstract] [Full Text] [Related]
23. Patients sought for New Zealand multi-centre Parkinson's disease trial.
Wallis WE
N Z Med J; 1987 Jan; 100(816):33. PubMed ID: 3543760
[No Abstract] [Full Text] [Related]
24. A comparative study of bromocriptine and levodopa in Parkinson's disease.
Duvoisin RC; Mendoza MM; Yahr MD
Adv Biochem Psychopharmacol; 1980; 23():271-5. PubMed ID: 7395618
[No Abstract] [Full Text] [Related]
25. Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.
Lieberman AN; Neophytides A; Leibowitz M; Gopinathan G; Pact V; Walker R; Goodgold A; Goldstein M
Adv Neurol; 1983; 37():95-108. PubMed ID: 6858782
[TBL] [Abstract][Full Text] [Related]
26. Long-term use of dopamine agonists in Parkinson's disease.
Jankovic J
Clin Neuropharmacol; 1985; 8(2):131-40. PubMed ID: 3891082
[No Abstract] [Full Text] [Related]
27. Bromocriptine in Parkinson's disease.
Stern G; Lees A
Br J Hosp Med; 1978 Dec; 20(6):666-70. PubMed ID: 743580
[No Abstract] [Full Text] [Related]
28. A double-blind study of bromocriptine and L-dopa in de novo Parkinson's disease. Short-term results.
Riopelle RJ; Gawel MJ; Libman I; King DB; McLean DR; Paulseth R; Raphy B; Bouchard S
Eur Neurol; 1988; 28 Suppl 1():11-4. PubMed ID: 3288477
[TBL] [Abstract][Full Text] [Related]
29. [Letter: Effect of bromocryptine on the fluctuations following dopa therapy. On-off phenomenon in parkinsonian patients].
Frattola L; Albizzati MG; Spano PF; Trabucchi M
Nouv Presse Med; 1976 Aug 28-Sep 4; 5(28):1761. PubMed ID: 958891
[No Abstract] [Full Text] [Related]
30. Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
Kartzinel R; Shoulson I; Calne DB
Neurology; 1976 Jun; 26(6 PT 1):511-3. PubMed ID: 778655
[TBL] [Abstract][Full Text] [Related]
31. [Bromocriptine and Parkinson's disease: initial results].
Petit H; Destee A
Lille Med; 1977; 22(6):362-5. PubMed ID: 578286
[No Abstract] [Full Text] [Related]
32. A progress report on the New Zealand Multicentre Parkinson's disease trial. A comparison of low-dose treatment with bromocriptine or L-dopa.
Wallis WE
Eur Neurol; 1988; 28 Suppl 1():9-10. PubMed ID: 3288479
[TBL] [Abstract][Full Text] [Related]
33. Further experiences with low doses of bromocriptine in Parkinson's disease.
Fahn S; Côté LJ; Barrett RE; Snider SR
Adv Biochem Psychopharmacol; 1980; 23():255-60. PubMed ID: 7395615
[No Abstract] [Full Text] [Related]
34. Bromocriptine versus placebo in levodopa treated patients with Parkinson's disease.
Gron U
Acta Neurol Scand; 1977 Sep; 56(3):269-73. PubMed ID: 333855
[TBL] [Abstract][Full Text] [Related]
35. Pergolide and Parkinson's disease: new preparation. No clear benefit.
Prescrire Int; 2000 Dec; 9(50):177-9. PubMed ID: 11475497
[TBL] [Abstract][Full Text] [Related]
36. [Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study].
Montastruc JL; Rascol O; Rascol A
Rev Neurol (Paris); 1990; 146(2):144-7. PubMed ID: 2181588
[TBL] [Abstract][Full Text] [Related]
37. Clinical studies with bromocriptine in idiopathic parkinsonism.
Teychenne PF; Kartzinel R; Perlow M; Pfeiffer R; Calne DB
Trans Am Neurol Assoc; 1976; 101():302-4. PubMed ID: 1037483
[No Abstract] [Full Text] [Related]
38. Dopaminephilic properties of ergot alkaloids.
Goldstein M; Lew JY; Nakamura S; Battista AF; Lieberman A; Fuxe K
Fed Proc; 1978 Jun; 37(8):2202-6. PubMed ID: 26607
[No Abstract] [Full Text] [Related]
39. The Sydney multicentre study of Parkinson's disease. The first 18 months.
Hely MA; Morris JG; Rail D; O'Sullivan DJ; Williamson PM; Genge S; Reid WG; Broe GA
Med J Aust; 1987 Feb; 146(4):195-8. PubMed ID: 3553878
[TBL] [Abstract][Full Text] [Related]
40. An evaluation of bromocriptine in the treatment of Parkinson's disease.
Mackenzie RA; Lance JW
Clin Exp Neurol; 1978; 15():228-36. PubMed ID: 386307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]